Current Projects

The physician’s of Orthopedic Institute actively participate in emerging research technologies, providing patients access to new therapies and diagnostics.

Here are the New and Exciting Opportunities for Treatment Currently Available at HRI

 

Osteoarthritis of the Knee    

• Patients must be 18 years of age or older.
• Diagnosed with Osteoarthritis of the Knee.
• Patient who are unwilling/unable to take non-opiate pain medications (NSAID’s), or have inadequate pain relief from NSAD’s, or are candidates seeking invasive intervention of the knee.
• Must be willing to discontinue all pain medications for OA of the knee during trial participation.
• Able and willing to give written informed consent and comply with the requirements of the study protocol.
• Other inclusion/exclusion criteria apply.

Opioid-experienced patients with moderate to severe chronic low back pain

• Patient must be 18 years of age or older.
• Predominant chronic back pain for at lest 3 months.
• Patients with average pain >5 (on a 11-point numerical pane scale where 0 = no pain and 10 = worst pain imaginable).
• Must be willing to discontinue all analgesic and steroid medications for back pain.
• Other inclusion/exclusion criteria apply.

 

Rheumatoid Arthritis

• Patient must be over 18 years of age or older.
• Diagnosed with moderate to severe active Rheumatoid Arthritis, who have failed MTX therapy and are naïve to RA biologic DMARD therapy.
• Patients must have had a confirmed diagnosis of RA for less than 5 years.
• Patients must be willing to self-inject the study medication or to have a caregiver do it for them.
• Able and willing to give written informed consent and comply with the requirements of the study protocol.
• Other inclusion/exclusion criteria apply.

 

Current Acute Gout Flare

• Male or female patients age 18-85.
• Onset of current acute gout flair within 5 days.

• Able and willing to give written informed consent and comply with the requirements of the study protocol.
• Other inclusion/exclusion criteria apply.

 

Chronic Low Back Pain

• Male and female patients age 18-70.
• Diagnosed with chronic low back pain  for more than 3 months.
• Patients must be taking NSAIDs or non-opioid analgesics for at lest 4 weeks and intended to remain on a stable dose of this agents for the duration of the study.
• Patients should be able to apply study medication patches at home.

• Able and willing to give written informed consent and comply with the requirements of the study protocol.
• Other inclusion/exclusion criteria apply.

 

 

 

For more information please call 405.616.4888 or email HRI with any questions in regards to these studies.